$1,499.00
Quantity: ~1M viable cells
CIRM Line ID: CW20300
Disease: Healthy Donor
Gender: Male
Sampled age: 10
Ethinicity: Caucasian, not Latino
Description
Quantity: ~1M viable cells
CIRM Line ID: CW20300
Disease: Healthy Donor
Gender: Male
Sampled age: 10
Race: Caucasian, not Latino
Donor data
Demographic (source: CIRM) | Description | CONTROL: NO ASD, CP, EPILEPSY OR ID, POPULATION CONTROL |
Affected Status | No | |
Product | iPSC | |
Source | PBMC | |
Sex | Male | |
Age at Sampling | 10 YR | |
Race | Caucasian | |
Ethnicity | Not Hispanic or Latino | |
Publications Cited | 0 | |
dbGap | No | |
Biopsy Source | Blood | |
Collection | Control,Neurodevelopmental Disorders | |
Cell Type | Stem Cell | |
Tissue Type | Induced pluripotent stem cell | |
Transformant | Episomal | |
Species | sapiens | |
Common Name | human | |
Detailed Clinical Data | false | |
Clinical data (source: CIRM) | ASDMedicalFamilyHistory | ASDMedicalFamilyHistory |
Diagnosis | Healthy Control | |
Birthweight_(kgs) | 4.42 | |
Birth_order | 2 | |
Birth_order_notes | Second born | |
Number_of_siblings_(includes_half_and_whole_siblin | 1 | |
Weight_% | 97 | |
Head_Circumference_(cm) | 53.8 | |
Maternal_age_(years) | 42 | |
Maternal_age_at_delivery_(years) | 32 | |
Paternal_age_(years) | 40 | |
Paternal_age_at_delivery_(years) | 30 | |
Consanguinity | Unknown | |
ASDSharedControl | ASDSharedControl | |
Physical_exam_negative_for_any_dysmorphologies_or_ | Yes | |
Intelligence_Quotient_(IQ)_data_available | Yes | |
Full_Scale_IQ | 116 | |
Verbal_IQ | 117 | |
Nonverbal_IQ | 111 | |
Test_used | WASI | |
Other_test_used | WASI-II | |
Autism_Screening_Questionnaire_-_Social_Communicat | 1 |
- Users do not need any additional license for the use of these differentiated cells even when cells are used for high throughput screening or drug discovery.
- All donor consents include statements on the following:
- Testing the cells’ DNA (this is referred to as the cell’s genetic code or sequence) and making the information known to other researchers
- Changing some of the genetic code or sequence within these cells
- Using cells to test or select drugs to treat disease
- Transplanting cells or resulting products to humans or animals
Distributing cells widely (nationally and internationally) for research, training or commercial medical product development - Future research and uses unforeseen at this time
- Donors were screened and negative for HIV, HBV, and HCV. Donors under the age of 18 could opt out of HIV testing; all HCV-positive donors submitted skin punches, not peripheral blood, and were not screened for any infectious agents due to small volume of blood present in punches.
- Human induced pluripotent stem cells were established by non-integrating episomal reprogramming. Reprogramming and quality control were performed by Cellular Dynamics International.
Characteristics
Please refer this page for some characteristics data.